Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Methods for diagnosing an inflammatory bowel disease based on soluble tumor necrosis factor II (sTNFRII) levels in a patient sample and treating thereafter

US Patent 12332253 · Granted Jun 17, 2025

Assignee

Inventors

View full patent text on Google Patents →